Keros Therapeutics (KROS) Shares Outstanding (2019 - 2025)

Keros Therapeutics (KROS) Shares Outstanding (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 6,012.74 Bn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 47.82 Bn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.44 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 400.00 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 62.06 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 Keros Therapeutics 374.82 Mn 87.42 Mn - 37.22 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 37.22 Mn
Sep 30, 2025 40.62 Mn
Jun 30, 2025 40.61 Mn
Mar 31, 2025 40.56 Mn
Dec 31, 2024 37.44 Mn
Sep 30, 2024 37.59 Mn
Jun 30, 2024 36.10 Mn
Mar 31, 2024 35.69 Mn
Dec 31, 2023 29.45 Mn
Sep 30, 2023 29.67 Mn
Jun 30, 2023 29.60 Mn
Mar 31, 2023 28.37 Mn
Dec 31, 2022 25.24 Mn
Sep 30, 2022 25.55 Mn
Jun 30, 2022 24.05 Mn
Mar 31, 2022 23.99 Mn
Dec 31, 2021 23.33 Mn
Sep 30, 2021 23.36 Mn
Jun 30, 2021 23.31 Mn
Mar 31, 2021 23.23 Mn